Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 69081 - 69100 out of 561238 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Belgium | (L01EX08) lenvatinib | LENVIMA 10 mg | 30 capsules, hard, 10 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | EISAI |
| Belgium | (L01EX08) lenvatinib | LENVIMA 4 mg | 30 capsules, hard, 4 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | EISAI |
| Belgium | (L01EX08) lenvatinib | LENVIMA 4 mg (Abacus) | 30 capsules, hard, 4 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | ABACUSMEDICINE |
| Belgium | (L01EX09) nintedanib | VARGATEF 100 mg | 120 capsules, zacht, 100 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BOEHRINGERINGELHEIMSCOMM |
| Belgium | (L01EX09) nintedanib | VARGATEF 150 mg | 60 capsules, zacht, 150 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BOEHRINGERINGELHEIMSCOMM |
| Belgium | (L01EX10) midostaurin | RYDAPT 25 mg | 56 mg capsules, zacht, 25 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute; Mastocytosis | NOVARTISPHARMA |
| Belgium | (L01EX13) gilteritinib | XOSPATA 40 mg | 84 filmomhulde tabletten, 40 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | ASTELLASPHARMA |
| Belgium | (L01EX14) entrectinib | ROZLYTREK 100 mg | 30 capsules, hard, 100 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer; Carcinoma, Non-Small-Cell Lung | ROCHE |
| Belgium | (L01EX14) entrectinib | ROZLYTREK 200 mg | 90 capsules, hard, 200 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer; Carcinoma, Non-Small-Cell Lung | ROCHE |
| Belgium | (L01EX14) entrectinib | ROZLYTREK 200 mg (Abacus) | 90 capsules, hard, 200 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer; Carcinoma, Non-Small-Cell Lung | ABACUSMEDICINE |
| Belgium | (L01EX22) selpercatinib | RETSEVMO 40 mg | 168 capsules, hard, 40 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Thyroid Neoplasms | ELILILLYBENELUX |
| Belgium | (L01EX22) selpercatinib | RETSEVMO 80 mg | 112 capsules, hard, 80 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Thyroid Neoplasms | ELILILLYBENELUX |
| Belgium | (L01EX23) pralsetinib | GAVRETO 100 mg | 120 capsules, hard, 100 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ROCHE |
| Belgium | (L01FA01) rituximab | TRUXIMA 100 mg (Orifarm) | 2 injectieflacons 10 mL concentraat voor oplossing voor infusie, 10 mg/mL | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Wegener Granulomatosis; Leukemia, Lymphocytic, Chronic, B-Cell; Microscopic Polyangiitis | ORIFARMBELGIUM |
| Belgium | (L01FA01) rituximab | TRUXIMA 500mg (Orifarm) | 1 injectieflacon 50 mL concentraat voor oplossing voor infusie, 10 mg/mL | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Wegener Granulomatosis; Leukemia, Lymphocytic, Chronic, B-Cell; Microscopic Polyangiitis | ORIFARMBELGIUM |
| Belgium | (L01FD01) trastuzumab | HERZUMA 150 mg (Orifarm) | 1 injectieflacon 150 mg poeder voor concentraat voor oplossing voor infusie, 150 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | ORIFARMBELGIUM |
| Belgium | (L01FD01) trastuzumab | HERZUMA 420 mg (Orifarm) | 1 injectieflacon 420 mg poeder voor concentraat voor oplossing voor infusie, 420 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | ORIFARMBELGIUM |
| Belgium | (L01FD01) trastuzumab | HERZUMA 150 mg | 1 injectieflacon 150 mg poeder voor concentraat voor oplossing voor infusie, 150 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | CELLTRIONHEALTHCAREBELGIUMBVBA |
| Belgium | (L01FD01) trastuzumab | KANJINTI 150 mg | 1 injectieflacon 150 mg poeder voor concentraat voor oplossing voor infusie, 150 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | AMGEN |
| Belgium | (L01FD01) trastuzumab | ONTRUZANT 150 mg | 1 injectieflacon 150 mg poeder voor oplossing voor infusie, 150 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | ORGANONBELGIUMBV |
Pages
